Summary Safety Review - Selective Serotonin Reuptake Inhibitors (SSRIs) - Assessing the Potential Risk of Autism

Description

Health Canada reviewed this issue because a published study found a link between SSRI exposure during pregnancy and an increased risk of autism in children. Autism is a developmental disability with lifelong impact. It affects a child's ability to communicate and interact with others.

Resources

Name Format Description Link
Summary Safety Review - Selective Serotonin Reuptake Inhibitors (SSRIs) - Assessing the Potential Risk of Autism HTML https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/safety-reviews/summary-safety-review-selective-serotonin-reuptake-inhibitors-risk-autism.html
Summary Safety Review - Selective Serotonin Reuptake Inhibitors (SSRIs) - Assessing the Potential Risk of Autism HTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medeffet-canada/examens-innocuite/resume-examen-innocuite-inhibiteurs-selectifs-recaptage-serotonine-isrs-risque-autisme.html

Tags

Topics

Categories